CTS Corporation Announces Appointment of Kimberly Banks MacKay to its Board of Directors
CTS (NYSE: CTS) announced the appointment of Kimberly Banks MacKay to its Board of Directors, effective November 5, 2025. She will serve on the Nominating, Governance and Sustainability Committee and the Technology and Transactions Committee.
Ms. MacKay has over 30 years of experience in multinational companies and currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services. She also holds board and committee roles with the Community Foundation of New Jersey and BAYADA Home Health Care. Company leadership said her healthcare and global business experience supports CTS’s focus on growth, end-market diversification, and its products that sense, connect and move.
CTS (NYSE: CTS) ha annunciato la nomina di Kimberly Banks MacKay nel Consiglio di Amministrazione, con effetto 5 novembre 2025. Resterà nel Comitato per la Nomina, la Governance e la Sostenibilità e nel Comitato Tecnologia e Transazioni.
La signora MacKay vanta oltre 30 anni di esperienza in aziende multinazionali e ricopre attualmente il ruolo di SVP, Avvocato Generale e Segretario societario di West Pharmaceutical Services. Inoltre ricopre ruoli in consigli e comitati presso la Community Foundation of New Jersey e BAYADA Home Health Care. Secondo la leadership dell'azienda, la sua esperienza nel settore sanitario e a livello globale sostiene l'obiettivo di CTS di crescita, diversificazione dei mercati finali e dei suoi prodotti che sensano, connettono e fanno muovere.
CTS (NYSE: CTS) anunció el nombramiento de Kimberly Banks MacKay en su Junta Directiva, con efecto a partir del 5 de noviembre de 2025. Desarrollará funciones en el Comité de Nombramientos, Gobernanza y Sostenibilidad y en el Comité de Tecnología y Transacciones.
La Sra. MacKay tiene más de 30 años de experiencia en compañías multinacionales y actualmente se desempeña como Vicepresidenta Senior, Consejera General y Secretaria Corporativa de West Pharmaceutical Services. También ocupa puestos en la junta y comités de la Community Foundation of New Jersey y BAYADA Home Health Care. Según la dirección de la empresa, su experiencia en atención sanitaria y en negocios globales respalda el enfoque de CTS en crecimiento, diversificación de mercados finales y en sus productos que perciben, conectan y hacen avanzar.
CTS (NYSE: CTS)가 이사회로의 Kimberly Banks MacKay 임명을 발표했으며, 효력은 2025년 11월 5일부터입니다. 그녀는 지명, 거버넌스 및 지속 가능성 위원회와 기술 및 거래 위원회에서 활동할 예정입니다.
맥케이 여사는 다국적 기업에서 30년이 넘는 경력을 보유하고 있으며 현재 West Pharmaceutical Services의 SVP, 총괄 고문 및 회사 비서로 재직 중입니다. 또한 그녀는 Community Foundation of New Jersey와 BAYADA Home Health Care의 이사회 및 위원회 역할도 맡고 있습니다. 회사 측은 그녀의 헬스케어 및 글로벌 비즈니스 경험이 CTS의 성장, 시장 다각화 및 감지하고 연결하며 움직이는 제품에 대한 집중을 뒷받침한다고 밝혔습니다.
CTS (NYSE: CTS) a annoncé la nomination de Kimberly Banks MacKay au conseil d'administration, à effet à partir du 5 novembre 2025. Elle siègera au sein du Comité de nomination, de gouvernance et de durabilité et du Comité Technologie et Transactions.
Mme MacKay possède plus de 30 ans d'expérience dans des sociétés multinationales et occupe actuellement les fonctions de SVP, Conseillère générale et Secrétaire d'entreprise chez West Pharmaceutical Services. Elle occupe également des postes au sein du conseil et de comités de la Community Foundation of New Jersey et BAYADA Home Health Care. La direction a déclaré que son expérience dans les soins de santé et les affaires mondiales soutient l'objectif de CTS axé sur la croissance, la diversification des marchés finaux et sur ses produits qui perçoivent, connectent et font bouger.
CTS (NYSE: CTS) kündigte die Berufung von Kimberly Banks MacKay in den Vorstand an, mit Wirkung zum 5. November 2025. Sie wird dem Nominating, Governance and Sustainability Committee und dem Technology and Transactions Committee angehören.
Frau MacKay verfügt über mehr als 30 Jahre Erfahrung in multinationalen Unternehmen und bekleidet derzeit die Position der SVP, General Counsel und Corporate Secretary bei West Pharmaceutical Services. Sie übt außerdem Aufsichtsrat- und Ausschussfunktionen bei der Community Foundation of New Jersey und BAYADA Home Health Care aus. Die Unternehmensleitung sagte, dass ihre Gesundheitsbranche- und globale Geschäftserfahrung CTSs Fokus auf Wachstum, Endmarktdiversifizierung und auf Produkte, die fühlen, verbinden und bewegen unterstützt.
CTS (NYSE: CTS) أعلنت عن تعيين Kimberly Banks MacKay في مجلس إدارتها، اعتباراً من 5 نوفمبر 2025. ستشغل مقعد في لجنة الترشيحات والحوكمة والاستدامة و لجنة التكنولوجيا والصفقات.
السيدة ماكاي لديها أكثر من 30 عامًا من الخبرة في الشركات متعددة الجنسيات وتعمل حالياً كنائب رئيسي أول، المستشار العام وكاتب الشركة في West Pharmaceutical Services. كما أنها تشغل أدواراً في مجالس ولجان في Community Foundation of New Jersey و BAYADA Home Health Care. وقالت قيادات الشركة إن خبرتها في الرعاية الصحية والأعمال العالمية تدعم تركيز CTS على النمو، تنويع الأسواق النهائية و"منتجاتها التي تشعر، وتربط وتدفع الحركة.
- None.
- None.
LISLE, Ill., Nov. 06, 2025 (GLOBE NEWSWIRE) -- CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced that Kimberly Banks MacKay has been appointed to its Board of Directors, effective November 5, 2025, and that she will serve as a member of the Nominating, Governance and Sustainability Committee, as well as the Technology and Transactions Committee.
Ms. MacKay comes to CTS with over 30 years of experience driving results in multi-national companies serving key end markets. Ms. MacKay currently serves as SVP, General Counsel and Corporate Secretary of West Pharmaceutical Services, Inc. Ms. MacKay is also a member of the Board of the Community Foundation of New Jersey, and the Compliance, Audit and Risk Committee for BAYADA Home Health Care.
"CTS is pleased to welcome Kimberly MacKay to the CTS Board. Her extensive experience in healthcare and background leading global businesses make her a valuable addition to our already highly experienced, diverse group of directors, as CTS continues to focus on growth, end-market diversification, and products that sense, connect and move," said Kieran O’Sullivan, Chairman, President and CEO of CTS.
About CTS
CTS (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect, and Move. The company manufactures sensors, actuators, and electronic components in North America, Europe, and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical, and transportation markets. For more information, visit www.ctscorp.com.
Contact
Ashish Agrawal
Vice President and Chief Financial Officer
CTS Corporation
4925 Indiana Avenue
Lisle, IL 60532
USA
Telephone: +1 (630) 577-8800
Email: ashish.agrawal@ctscorp.com
FAQ
When did CTS (CTS) appoint Kimberly Banks MacKay to its board?
What committees will Kimberly MacKay join on the CTS board (CTS)?
What is Kimberly MacKay’s current role before joining CTS (CTS)?
How does Kimberly MacKay’s background relate to CTS’s strategy (CTS)?
Does Kimberly MacKay hold other board or committee positions while joining CTS (CTS)?
